Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapy

BACKGROUND: Gemcitabine/Cisplatin (Gem/CDDP) combination has demonstrated a clear survival advantage over gemcitabine alone and has become a new standard in advanced Biliary Tract Carcinoma (aBTC). However, Gemcitabine/Oxaliplatin (GEMOX) combination and Gemcitabine/Carboplatin (Gem/Carb) combinatio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Gastroenterol
Main Authors: Fiteni, Frédéric, Jary, Marine, Monnien, Franck, Nguyen, Thierry, Beohou, Eric, Demarchi, Martin, Dobi, Erion, Fein, Francine, Cleau, Denis, Fratté, Serge, Nerich, Virginie, Bonnetain, Franck, Pivot, Xavier, Borg, Christophe, Kim, Stefano
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4236575/
https://ncbi.nlm.nih.gov/pubmed/25117717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-230X-14-143
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados